Influence of the Number of Axial Bexarotene Ligands on the Cytotoxicity of Pt(IV) Analogs of Oxaliplatin.

about

Influence of the Number of Axial Bexarotene Ligands on the Cytotoxicity of Pt(IV) Analogs of Oxaliplatin.

Item

http://www.wikidata.org/entity/Q41212195

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Influence of the Number of Axi ...... Pt(IV) Analogs of Oxaliplatin.

@en

type

Item

label

Influence of the Number of Axi ...... Pt(IV) Analogs of Oxaliplatin.

@en

prefLabel

Influence of the Number of Axi ...... Pt(IV) Analogs of Oxaliplatin.

@en

P1476

Influence of the Number of Axi ...... Pt(IV) Analogs of Oxaliplatin

@en

P2093

Bernhard K Keppler

http://www.w3.org/2001/XMLSchema#string

Ilia V Zenin

http://www.w3.org/2001/XMLSchema#string

Markus Galanski

http://www.w3.org/2001/XMLSchema#string

Olga N Kovaleva

http://www.w3.org/2001/XMLSchema#string

Varvara P Maximova

http://www.w3.org/2001/XMLSchema#string

Yulia N Nosova

http://www.w3.org/2001/XMLSchema#string

P2860

INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE

The status of platinum anticancer drugs in the clinic and in clinical trials

Cisplatin: mode of cytotoxic action and molecular basis of resistance

Anticancer activity of methyl-substituted oxaliplatin analogs.

Conjugates of cisplatin and cyclooxygenase inhibitors as potent antitumor agents overcoming cisplatin resistance.

Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes

Conjugation of cisplatin analogues and cyclooxygenase inhibitors to overcome cisplatin resistance.

Topical and systemic retinoid therapy for cutaneous T-cell lymphoma.

Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin.

A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy

P304

4736321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/4736321

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28804273

http://www.w3.org/2001/XMLSchema#string

P921

cytotoxicity

P932

5540250

http://www.w3.org/2001/XMLSchema#string